本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

147.01
+10.717.86%
盘后146.95-0.0600-0.04%19:57 EDT
成交量:820.23万
成交额:11.74亿
市值:291.33亿
市盈率:-24.71
高:148.00
开:136.50
低:134.66
收:136.30
52周最高:148.00
52周最低:34.00
股本:1.98亿
流通股本:1.79亿
量比:2.03
换手率:4.58%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-5.9502
净资产收益率:-58.07%
总资产收益率:-30.08%
市净率:17.86
市盈率(LYR):-24.71

数据加载中...

2023/08/02

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

重要事件披露

Form 8-K - Current report
2023/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/16

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/07

重要事件披露

8-K - Current report
2023/02/27

重要事件披露

8-K - Current report
2023/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans